Literature DB >> 24647384

A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour.

Leah L Zullig1, Linda L Sanders, Ryan J Shaw, Felicia McCant, Susanne Danus, Hayden B Bosworth.   

Abstract

We conducted a feasibility study of a web-based intervention, which provided personalized cardiovascular disease (CVD) risk information, behavioural risk reduction strategies and educational resources. Participants were block-randomized to the 3-month intervention (n = 47) or to usual care (n = 49). Participants in the intervention group were presented with their CVD risk based on the Framingham risk score, and in three subsequent online encounters could select two behavioural/lifestyle modules, giving them an opportunity to complete six modules over the course of the study. Because it was self-guided, participants had differing levels of engagement with intervention materials. Most intervention group participants (77%, n = 36) completed all modules. After 3 months there were no significant differences between the intervention and usual care groups for systolic blood pressure, body-mass index, CVD risk, smoking cessation or medication non-adherence. The study suggests that modest clinical improvements can be achieved by interventions that are entirely web-administered. However, web-based interventions do not replace the need for human interaction to communicate CVD risk and assist with decision-making.

Entities:  

Mesh:

Year:  2014        PMID: 24647384     DOI: 10.1177/1357633X14528446

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  8 in total

Review 1.  Stopping the rise of HIV among adolescents globally.

Authors:  Mary Jane Rotheram-Borus; Emily Davis; Roxana Rezai
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

Review 2.  Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseases.

Authors:  Gerald S Bloomfield; Tracy Y Wang; L Ebony Boulware; Robert M Califf; Adrian F Hernandez; Eric J Velazquez; Eric D Peterson; Jennifer S Li
Journal:  Glob Heart       Date:  2015-03

Review 3.  Risk scoring for the primary prevention of cardiovascular disease.

Authors:  Kunal N Karmali; Stephen D Persell; Pablo Perel; Donald M Lloyd-Jones; Mark A Berendsen; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-14

4.  Biomedical risk assessment as an aid for smoking cessation.

Authors:  Carole Clair; Yolanda Mueller; Jonathan Livingstone-Banks; Bernard Burnand; Jean-Yves Camain; Jacques Cornuz; Myriam Rège-Walther; Kevin Selby; Raphaël Bize
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

Review 5.  Internet-based interventions for smoking cessation.

Authors:  Gemma M J Taylor; Michael N Dalili; Monika Semwal; Marta Civljak; Aziz Sheikh; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2017-09-04

Review 6.  Web-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis.

Authors:  Cathrien R L Beishuizen; Blossom C M Stephan; Willem A van Gool; Carol Brayne; Ron J G Peters; Sandrine Andrieu; Miia Kivipelto; Hilkka Soininen; Wim B Busschers; Eric P Moll van Charante; Edo Richard
Journal:  J Med Internet Res       Date:  2016-03-11       Impact factor: 5.428

7.  Does information form matter when giving tailored risk information to patients in clinical settings? A review of patients' preferences and responses.

Authors:  Rebecca Harris; Claire Noble; Victoria Lowers
Journal:  Patient Prefer Adherence       Date:  2017-03-01       Impact factor: 2.711

Review 8.  Which eHealth interventions are most effective for smoking cessation? A systematic review.

Authors:  Huyen Phuc Do; Bach Xuan Tran; Quyen Le Pham; Long Hoang Nguyen; Tung Thanh Tran; Carl A Latkin; Michael P Dunne; Philip Ra Baker
Journal:  Patient Prefer Adherence       Date:  2018-10-08       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.